Center for Chemical Biology and Therapeutics

Collaboration Opportunities

Brandon Faubert, PhD

Brandon Faubert, PhD

Personal Profile

Research and Scholarly Interests: Cancer Metabolism, In Vivo Metabolism, Lung Cancer, Mass Spectrometry, Metastasis, Stable Isotope Tracing. Collaboration Interests

 

 

Raghu G Mirmira, MD PhD

Raghu G Mirmira, MD PhD

Personal Profile

Research and Scholarly Interest: The role of mRNA translation in the cellular response of islet ß cells to inflammation; the role of lipoxygenases in dysfunction of ß cells in Type 1 and Type 2 diabetes; and the identification of biomarkers of ß-cell stress and death in diabetes. Collaboration Interest

Grace Zhai, PhD

Grace Zhai, PhD

Personal Profile

Research and Scholarly Interest: Her research focuses on understanding the genetic and molecular mechanisms underlying neural degeneration and protection, particularly in the context of both rare and common neurological diseases. Collaboration Interest

Janane Rahbani, PhD

Janane Rahbani, PhD

Personal Profile

Research and Scholarly Interests: Adipocyte Biology, Cachexia, Cancer metabolism, Diabetes Mellitus, Type II, Metastasis, Obesity. Collaboration Interest

Conghui Yao, PhD

Conghui Yao, PhD

Personal Profile

Research and Scholarly Interests: Cancer Metabolism, Immunometabolism, Metabolomics Collaboration Interest

Sarah Tersey, PhD

Sarah Tersey, PhD

Personal Profile

Research and Scholarly Interests: Diabetes, Endoplasmic Reticulum Stress, Insulin, Oxidative Stress, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, β cell Collaboration Interest

Marina Chiara Garassino, MD

Marina Chiara Garassino, MD

Personal Profile

Research and Scholarly Interests: Thoracic tumors including lung cancer, non-small cell lung cancer and small cell lung cancer, as well as thymic malignanicies, very rare mediastinal tumors (tumors that develop between the chest and breastbone).Collaboration Interest

Olatoyosi Odenike, MD

Olatoyosi Odenike, MD

Personal Profile

Research and Scholarly Interests: Dr. Odenike’s research is focused on the development of novel therapeutic agents for the treatment of acute and chronic leukemias, and chronic myeloproliferative diseases, with the ultimate goal of improving treatment options for patients with these diseases.Collaboration Interest

Scroll to Top